Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.01M Sell
108,399
-3,103
-3% -$61.8K 0.01% 1108
2026
Q1
$2.1M Sell
111,502
-3,403
-3% -$63.9K 0.01% 997
2025
Q4
$1.8M Buy
114,905
+7,292
+7% +$108K 0.01% 1083
2025
Q3
$1.43M Buy
107,613
+31,243
+41% +$404K 0.01% 1220
2025
Q2
$949K Buy
76,370
+4,798
+7% +$60.4K ﹤0.01% 1419
2025
Q1
$1.09M Buy
71,572
+10,911
+18% +$163K ﹤0.01% 1333
2024
Q4
$886K Buy
60,661
+14,889
+33% +$233K ﹤0.01% 1427
2024
Q3
$731K Sell
45,772
-19,475
-30% -$346K ﹤0.01% 1530
2024
Q2
$1.24M Buy
65,247
+25,059
+62% +$470K 0.01% 1196
2024
Q1
$784K Buy
40,188
+16,926
+73% +$315K ﹤0.01% 1445
2023
Q4
$472K Buy
+23,262
New +$457K ﹤0.01% 1537

Other funds holding NOV

Pathstone Holdings's NOV Position: Q2 2026 in Review

Pathstone Holdings reduced its NOV (NOV) stake by 2.8% in Q2 2026, selling an estimated $61.8K and leaving 108,399 shares worth $2.01M. The position accounts for 0.01% of the portfolio, ranked #1108.

Pathstone Holdings first reported a position in NOV in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.1M in Q1 2026. 486 funds tracked by Wall St. Rank hold NOV as of Q2 2026.

  • Pathstone Holdings held 108,399 shares of NOV worth $2.01M as of Q2 2026.
  • Pathstone Holdings sold 3,103 NOV shares in Q2 2026, an estimated $61.8K.
  • NOV made up 0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1108 holding.
  • Pathstone Holdings first reported a position in NOV in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's NOV position peaked at $2.1M in Q1 2026.
  • 486 funds tracked by Wall St. Rank held NOV as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.